Analysis Life Sciences Thank You The 51 regulations that FDA is currently working on
Agency IQ
JUNE 16, 2023
FDA is proposing to establish the criteria by which it would evaluate drug products and categories of drug products for inclusion on the list of drug products and categories of drug products that present demonstrable difficulties for compounding under section 503A and/or under section 503B.
Let's personalize your content